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THE present experiments are concerned with the state of the ovaries including
the process of tumour formation, following skin applications of four chemical
carcinogens to virgin mice of the IF strain. Howell, Marchant and Orr (1954)
showed that skin applications of 9: 10-dimethyl-I :2-benzanthracene induced a
bigh incidence of ovarian tumours in inbred or hydrid virgin mice of this strain
as compared with three other inbred strains. Marchant (1957) also tested 20-
methylcholanthrene in a small number of mice of IF origin and obtained a few
microscopical tumours. In a previous paper (Mody, 1960) the normal virgin IF
ovary at various ages was described and it was shown that frequent spontaneous
pseudopregnancy occurs in grouped virgins.
MATERIAL AND METHODS
IF virgin females, approximately sixteen weeks old, were subjected to four
fortnightly skin applications of an 0-5 per cent solution of a chemical carcinogen
(obtained from L. Light & Co. Ltd., Colnbrook) in aracbis oil. At each painting
I ml. ofthe solution was applied as 8 drops to the dorsal and 8 drops to the ventral
side ofthe entire trunk surface. The animals in each group were killed in batches
at 0-3, 4-7. 8-11, and 12-15 weeks from the date of commencement of painting
and from then onwards at 8-weekly intervals until 70 weeks. The organs were
examined and the tissues fixed, cut and stained as described by Mody (1960).
Between 8 and 12 weeks after the start of treatment a batch of 4 mice from each
group was used for a dailv three-week study of the vaginal smear.
The groups comprised:
(i) Sixty females treated with 9: 10-dimethyl-I :2-benzanthracene
(DMB).
(h) Fifty-three females treated with 3 : 4-benzpyrene (BP).
(iii) Thirty-seven females treated with 20-methyleholanthrene (MC).
(iv) Sixty females treated with I : 21 : 5 : 6-dibenzanthracene (DB).
RESULTS
Incidence and Age ofAppearance of Ovarian Tumour8
Table I shows the number of tumours obtained with four chemical carcinogei-is,
the age being counted from the date of the first painting. The tumours range(I
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from microscopical size to I cm. or more in diameter. Twelve tumours were
obtained in DMB-treated mice, 4 in BP-treated and a doubtful early tumour in
MC-treated, while none occurred in the DB-group. In addition, early tumours
which could not be identified with certainty occurred in 4 DMB- and 4 BP-treated
mice. All the tumours occurred prior to 52 weeks from the commencement of
treatment.
Po-st-mortem Appearance of the Ovarie8
At autopsy the treated ovaries were either normal, enlarged or reduced in
size, the ovaries on the two sides being often of different sizes. On the whole the
ovaries appeared normal to the naked eye until 33 weeks from the start of treat-
ment and from then on showed varying degrees of enlargement culminatina in
haemorrhagic or non-haemorrhagic cysts or tumours ; at later ages many ovaries
were small and shrunken. In the DB-treated mice, however, the ovaries showed
no effect of the paintings but underwent a reduction in size with advancing age
comparable to that described for untreated mice (Mody, 1960).
Cysts and tumours were always unilateral and the opposite ovaries were
reduced or normal in size. Tumorous ovaries were observed with the naked eye
only in DMB- and BP-treated mice. Seven DMB-treated mice had grossly
detectable tumours between 16 and 51 weeks, 6 being in the right ovary. The
tumours ranged from 7 mm. to 2 cm. in diameter and were fleshy pink, grey or
yellowish-white in colour with darker areas of haemorrhage. The surface was
smooth and slightly lobulated, the consistency soft and there were s:)me
haemorrhagic cysts. The larger tumours had loose fibrous adhesions with the
peritoneal wall. In BP-treated mice two tumours were observed with the naked
eye: one seen at 55 weeks was 1-5 cm. in diameter, yellowish-white in colour,
with smooth surface and free from adhesions, while the other occurring at 31
weeks was only just recognisable and was greyish and slightly raised.
Hi8tology of the Tumour8
The tumours were classified as shown in Table 1: granulosa cell type (12),
mixed luteinised and granulosa cell type (2) and mixed thecal, luteinised and
granulosa cell type (1). In addition one luteoma was induced by BP. The
large tumours recognisable with the naked eye were all ofgranulosa cell type. In
addition to the above tumours, there were very early les-ions in 9 ovaries which
might have been tumorous but were not certainly so.
Granulosa cell tumour8
These were mainly of a compact pseudofollicular pattern. The pseudo-
follicles varied in size and resembled small anovular follicles. The central lumen
migbt be indistinct or contain some eosinophilic material, the latter type resembl-
ing Call and Exner bodies. Some of the granulosa cells composing the tumours
varied greatly in size and shape and showed mitosis, but most of the cells were
indistinguishable from normal granulosa cells (Fig. 1). Some tumours contained
papillary and cystic areas. The cysts were eitherlarge blood loculi, empty spaces
or contained eosinophilic fluid. All the tumours were free from lipochrome
pigment but in some there were small amounts of iron pigment in haemorrhagic
areas. The microscopical tumours were usually undifferentiated.258 JER K. MODY
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Mixed tumours
These were microscopical in size. In addition to granulosa cells, thev con-
tained luteinised cells (Fig. 2) and even thecal cells, the latter two cell types
showing no mitoses.
Luteomas
The one tumour of this type was microscopical in size and contained a central
organising haemorrhage. The component cells resembled normal lutein cells,
but were more variable in size and had irregular nuclei, rarely in mitosis (Fig. 3).
One-generation transplantation of a granulosa cell tumour
The single large granulosa cell tumour induced by BP was transplanted sub-
cutaneously into 6 mature IF male mice, in all of which palpable tumours about
2 cm. in diameterdeveloped by 16-19 weeks. Histologically thegrafted tumours
resembled theoriginal in structure. The mammaryglands ofthetumour-bearing
males showed lobular development while there was atrophy of the seminiferous
tubules and lack of secretion in the seminal vesicles. These changes were
regarded as due to hormone secretion by the transplant.
A. Processes Leading to Tumour Formation (DMB, BP, or MC)
These may be described under the following headings (Fig. 4):
Stage 1. Total loss of follicles.
Stage 2. Luteinisation.
Stage 3. Prominence of the germinal epithelium.
Stage 4. Occurrence of nodules.
Stage 5. Occurrence of tumours.
Total loss of follicles.-This is brought about by degeneration of all the
existingfollicles andfailure offurtherformationoffollicles. Theearliestdegenera-
FIG. 4.-Sequence ofchanges leading to granulosa ceR tumours.260 JER K. MODY
tion was noticed in the ova, followedbychanges in thegranulosa cells offollicles in
various stages of development (Fig. 5 and 6). These degenerative changes were
not distinguishable from follicular atresia occurring in untreated ovaries (Mody,
1960). With DMB, the onset of this stage is noticed within 3 weeks following
the first painting and after 16 weeks no follicles are seen. With BP and MC a few
follicles might be seen until 24 weeks foHowing the start of treatment. Atretic
remnants are found at all ages.
As in untreated mice, the thecal layers of follicles undergoing atresia do not
participate in the follicular degeneration. Instead the thecal cells either merge
with the extra follicular tissue or aggregates oflargepale dividing cellsresembling
thecal cells appear close to atretic follicles (Fig. 7).
Luteinisation.-At this stage two processes occur. Firstly, both young and old
intact corpora lutea merge prematurely due to the breaking away of the thecae.
This state may be referred to as diffuse luteinisation (Fig. 8). (It must be
distinguished from themerged corpora lutea found in untreated ovaries, the lutein
cells of which have completed their life span and are due to involute.) Apart
from this earlier merging the process of involution follows the same course as in
untreated ovaries and eventually leads to scattering of the degeneratinor lutein
cell cords. Secondly, among the lutein cell masses ofold anddegenerating corpora
lutea appear foci of theca-lutein or para-lutein cells, probably derived from the
dividing theca-type cell clusters observed in the vicinity of atretic follicles
(Fig. 7). This is atruly abnormal type of luteinisation. The newly luteinised cells
are large and polygonal and nuclei are variable in size and shape, being large,
round and vesicular (Fig. 9). These cells lie intermingled with the degenerated
remnants of corpora lutea and are often indistinguishable from them. The
intervening dark-staining spindle cells and reticulum fibres which form thin
septa and characteristically ensheath the small syncytia of theca-lutein cells are
helpful in distinguishing them from the corpus luteum cells. In spite of the
absence of follicles and intact corpora lutea the
" luteinised ovaries
" are not
smaller than normal ones.
In DMB-treated mice the phase of luteinisation is most prominent between
10 and 33 weeks after the start oftreatment but it may start earlier or maypersist
to a later age (Table 11). In BP-treated mice thecal luteinisation is somewhat
delayed. With MC merging of corpora lutea occurs within 7 weeks and diffuse
luteinisation is seen until 33 weeks, but thecal luteinisation is scanty. In all
three groups the lutein cells are filled with lipochrome pigment and possess a
TABLE II.-Microscopical Appearance ofDMB-, BP- and MC-treated Ovaries
I. DMB II. BP III. MC
r
Survival follow'mg
start of treatment 0-15 16--33 34-51 >52 0-15 16-33 34-51 >52 0-15 16-33 34-51 >52
Number of mice 20 18 16 6 17 11 20 5 16 15 6 0
Follicle
degeneration 12 - 17 2 16 1
Luteinisation 8 9 3 3 8 6 9 2 9 10
Prominence of ger-
minal epithelium 3 4 4 2 i 4 11 4 2 8 6
Nodules 5 1 2 2 2
Atrophy 5 7 9 2 3 10 3 1 6 6
Pigment 3 4 2 2 2 16 5 - 7 5
Cystic
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small pyknotic eccentric nucleus. Pigment filled phagocytes are also seen.
Fibrous scars, together with hyaline degeneration in the walls of arterioles or
vascular dilatation, are uncommon.
Prominence of the germinal epithelium.-Before the process of luteinisation is
complete the germinal epithelium becomes high cuboidal and the ovary may
become reduced in size. The prominence of the germinal epithelium is well
established 16 weeks following DMB treatment and is somewhat later with BP or
MC (Table 11). A few dark-staining cell aggregates are seen in the stroma, but
further proliferation of the germinal epithelium does not occur.
Occurrence ofnodules.-Microscopical, well-defined, single or multiple nodules
arising in areas of
" thecal luteinisation
" were found in the luteinised ovaries
(Fig. 8 and 10). The component cells have bizarre nuclei with large nucleoli
and the cytoplasm is less abundant than in the outer theca-lutein cells (Fig. 11).
A small central lymph space is sometimes present or may appear as the nodule
growslarger, at which timecapillaries surround it. As nodules grow they become
less well demarcated and their cells resemble granulosa cells, due to further
reduction in cytoplasm. Granulosa cell tumours arise in such foci (Fig. 12), the
tumour cells show mitotic activity. The tumours are always unilateral but as
nodules have been observed in both ovaries it is likely that regression of nodules
may occur.
Nodules were seen as early as 8 weeks following the start of DMB treatment
(i.e. just after its completion) but they also arose as late as 17 weeks (Table 11).
Early tumour foci were found in 3 ovaries between 25 and 60 weeks. With BP a
unilateral nodule was seen in the ovary in 2 mice between 12 and 15 weeks but
these two nodules were not as distinct as those in the DMB group. In addition,
a different variety of nodule was found in 2 mice between 34 and 51 weeks after
the start of BP-treatment. This second type of nodule was luteomatous, that is
composed of lutein cell cords indistinguishable from those of intact corpora lutea.
The nodules occupied a considerable portion of the ovary. Also in 4 normal
sized BP ovaries, at 23 to 52 weeks, there were unilateral ill-defined aggregates
ofgranulosa cells. In two ofthese tiny haemorrhagic areas were seen. As these
aggregates had neither ova nor thecae, they were not regarded as follicles but
because of their size they were possibly very early tumours. In two MC-treated
mice, a tiny nodule was seen in a noimal sized but luteinising ovary on one side
only at 22 and 27 weeks from the start of treatment. These nodules were of the
type found in the DMB group. In one normal sized MC-treated ovary an ill-
defined large granulosa cell cluster occurred at 27 weeks. It had neither ovum
nor thecal layers and occupied a large portion of the ovary. As follicles are not
found in MC-ovaries after 24 weeks, this might have been an early granulosa cell
tumour (Fig. 13).
Occurrence of tumours.-The histology of the fully formed tumours has been
described above.
B. Processes Leading to Non-tumorous Atrophy
All ovaries treated with DMB, BP or MC go through the stages of total loss
of follicles, luteinisation and prominence of the germinal epithelium but sub-
sequently the course of events changes in those that fail to develop nodules or
from which the nodules regress. Such ovaries undergo atrophic changes, often
unequal in degree on the two sides, and may finally become pinhead in size, i.e.262 JER K. MODY
less than I mm. in diameter. The contralateral ovary of a tumour-bearing mouse
undergoes atrophic changes of the same type. Qualitatively, these atrophic
changes (Fig. 14) are not different from those characteristic of the ageing ovary
of normal mice. The prominent germinal epithelium continue-3 to proliferate
and becomes multilayered or invaginated. The anovulai- buds lie in clumps near
the periphery and show no activity. The dark-staining cells stream inwards
from the epithelium and steadily replace the cells responsible for luteinisation
(Mody, 1960). In the degenerated lutein cells lipochrome pigment is seen which
may be taken up laterbyphagocytes. Cystic ovaries may be found occasionally.
In all the 12 mice bearing unilateral DMB-induced tumours of the granulosa
cell series the contralateral ovary was atrophic. Unilateral or bilateral atrophic
changes were studied in 25 DMB non-tumour-bearing mice, starting as early as
10 weeks after the beginning oftreatment. In BP-treated mice all 4 contralateral
ovaries of the tumour bearing mice were atrophic. In 21 of the non-tumour-
bearing mice treated with BP for over 16 weeks there were atrophic changes,
EXPLANATION OF PLATES
FIG. I.-Part of a large granulosa cefl tumour of compact pseudofollicular pattern. A large
cystic space containing fluid is seen towards the periphery. Thirty-five weeks after start of
DMB treatment. x 90.
FIG. 2.-Part of an early mixed tumour composed of luteinised and granulosa cells. The
cytoplasm in the luteinised cells is more abundant and pale staining. Fourteen weeks after
the start of DMB treatment. x 60.
FIG. 3.-Part of a luteoma showing cell cords similar to the lutein cells of the corpus luteum
but with a greater degree of variation in. size and shape of the nuclei. Thirty weeks after
start of BP treatment. x 375.
FIG. 5.-Stage of follicle degeneration. The compact dark outermost granulosa ceR layer is
particularly distinct in the large follicle (centre right) which is undergoing degeneration.
No degenerating cells arepresent in thesurrounding thecae. Atretic renmants andengorged
capillaries are seen. Towards bottom left are corpora lutea. Three weeks after start of
DMB treatment. x 90.
FIG. 6.-Earliestdegenerative changes seen in the ovum. Disintegration ofthe nucleus and fat
droplets in the cytoplasm. Three weeks after start of DMB treatment. x 340.
FIG. 7.-An aggregate of large pale theca-type cells in subgerniinal position and close to an
atretic follicular remnant. Some of the cells are in mitosis. Three weeks after start of DMB
treatment. x 285.
FIG. 8.-Total loss of follicles. Atretic remnants (AR) and diffuse luteinisation, due to pre-
maturemerging ofcorporalutea, can be seen. Atinynodule (N) towardstop centre in an area
of luteinisation. Eleven weeks after start of DMB treatment. x 70.
FIG. 9.-Two mitotic figures among luteinised ceRs, probably an area ofearly thecal luteinisa-
tion. Three weeks after start of DMB treatment. x 565.
FIG. IO.-A well-marked nodule towards top right in an area ofluteinisation. A capillary and
a lymphatic vessel are associated with it. Widespread luteinisation and scattered lymph
spaces. Eleven weeks after start of DMB treatment. x 75.
FIG. II.-A nodule surrounded by engorged capillaries in an area of luteinisation. The nuclei
of the cells within the nodule are closely packed and variable in size, shape and staining.
Aprominent nucleolus is often present. Eleven weeks after start of DMB treatment. X 195.
FIG. 12.-Two ill-defined nodules within an area of luteinisation. The component cells are
similar to those ofgranulosa cell tumours. Thirty-five weeks after start of DMB treatment.
x 75.
FIG. 13.-Doubtful tumour of granulosa cell type (the only one in the group), occupying a
considerable portion of the ovary. Twenty-seven weeks after start ofMC treatment. x 75.
FIG. 14.-Non-tumorous atrophy. Part of a reduced ovary with prominent germinal epithe-
lium, especially towards extreme right and clumps of anovular buds among dark-staining
epithelial cells towards the periphery. Pale pigment-laden degenerated lutein ceR towards
centre. Fifty weeks after start of DMB treatment. x 85.
FIG. 15.-Alarge number of intact corpora lutea. Some ofthe follicles are undergoing atresia.
No effect of the treatment visible. Fourteen weeks after start of DB treatment. (Compare
with Fig. 7 and 9 from DMB treated mice in the same age group.) x 30.Vol. XIV, No. 2. BRITISH JOURNAL OF CANCER.
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including 5 with cystic right ovaries. There was atrophy in one or both ovaries
in 2 of the 13 mice treated with MC for 16 weeks. Small fibrous scars together
with hyalinisation in the walls of arterioles and vascular dilatation were noticed
in these MC-treated ovaries.
C. Processes Leading to Senile Atrophy
The ovaries of mice treated with DB were similar to those of normal virgin
mice at comparable ages (Fig. 15), i.e. the changes characteristic ofsenility with
only minor differences took place (Table III). Graafian follicles were somewhat
TABLE III.-Microscopical Appearances of DB-treated Ovaries
Survival following start
of treatment* 0-15 16-33 34-51 >52
Number ofmice 17 12 24 7
Germinal epithelium Anovular buds + + + +
Dark staining cells + + + + + +
Follicles Primordial + + + + +
Graafian + + +
Atretic foRieles + + + +
Atretic renmants + + + + + +
Corporal lutea New + + + +
Old + + + + + + + +
Degenerating (early) + + + + + + +++
Degenerated + +++
Pigment + + + + + ++++
Fibrous scars + +
Add 16 weeks for actual age. (Compare with Table I, Mody, 1960.)
more frequent at older ages than in normal ovaries of the same ages. Cystic
follicles without haemorrhage, anovular follicles and corpora lutea atretica, i.e.
atretic follicles containinglipoids (Fekete, 1946), were occasionally observed while
they were rarely observed in normal ovaries. Intact young and old corpora
lutea persisted until about 30 weeks after treatment i.e. until 46 weeks of age.
Involution commenced within 4 weeks following the beginning of treatment and
the content ofdegenerating (thoseundergoing earlydegeneration) and completely
degenerated corpora lutea was greater than in normal ovaries, where more hpo-
chromepigment waspresent. The old DB-treated ovaries showed fibrousscarring
and hyaline degeneration in the walls of small arterioles, these changes being
uncommon in normal ovaries. Thus after DB treatment, total loss of follicles
and diffuse and thecal luteinisation were absent (Fig. 4). Prorninence of the
germinal epithelium was noted with age but proliferation and invaginations were
less evident than in normal ovaries. Senile atrophy was seen in 20 of the mice
treated with DB, the number ofpinhead or greatly reduced ovaries being larger
than in normal mice.
Uterus
On microscopical examination, the state of the uterus was classed as atrophic,
normal or having cystic hyperplasia. In 60 DMB-treated mice, ovarian tumours
were present in 12 and cystic hyperplasia occurred in 5 of these (Table IV). By
contrast, in 48 mice without ovarian tumours, cystichyperplasia of a lesserdegree
occurred in 3 mice. There is thus an association between ovarian tumours and
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cystic hyperplasia. When the size of the ovarian tumour was considered, it was
found that the largest were often not accompanied by cystic hyperplasia. Bali
TABLEIV.-State of the Uterus and Distribution of Breast Tumours in
Ovarian Tunwur-bearing and Non-tumour-bearing Mice
1. DMB IL BP III. MC IV. DB
Ovarian tumour present Cystic hyperplasia I
Cystic hyperplasia 4
+ breast tumour
Normal uterus 5
+ breast tumour
Normal uterus 2 3
without breast tumour
Ovarian tumour absent Cystic hyperplasia 2 3 2 2
Cystic hyperplasia 1 I 2
+ breast tumour
Norirnal uterus 5 I 5 6
+ breast tumour
Atrophy of uterus 6 3 3
Atrophy of uterus 6 I
+ breast tumour
and Furth (1949) made a similar observation and suggested that the oestrogenic
effects come to a standstill when the tumours reach about 2 cm. in diameter.
Vaginal Smear8
In view of the occurrence of spontaneous pseudopregnancy in normal IF
virgins kept in fours, a 3-week study of the vaginal smear was made in small
groups of treated mice 2 months after the start of treatment. Great individual
variation and irregularity in the length of the cycles was noticed among DMB-,
MC- and DB-treated mice. Dioestrug was long and oestrus short. By contrast,
in BP-treated mice a short 6-7 day cycle occurred, with oestrus of about 2 days,
and there was no mucification of the vagina at dioestrus. The cycle in BP-
treated mice is thus possibly different from that of normal virgins and similar
to that of anosmic mice (Mody, 1960). Further evidence is necessary to sub-
stantiate this.
Mammary Tumour8
Of 60 DMB-treated mice, ovarian and breast tumours were coincident in 9
out of 12, whereas breast tumours occurred in the absence of ovarian tumours in
6 out of 48 mice (Table IV). In BP-treated mice, none of the 4 ovarian tumours
was associated with a breast tumour. Twelve MC-and 9 DB-induced breast
tumours occurred in the absence ofovarian tumours. Thus, although there was a
high association between breast and ovarian tumours in DMB-treated mice, this
association did not hold for the other 3 carcinogens. Howell et al. (1954) found
that DMB-induced ovarian and breast tumours were dissociated, the distribution
being random.
DISCUSSION
Incidence of ovarian tumour8
The occurrence of 12 ovarian tumours in 60 IF mice following treatment with
DMB is a lower incidence than that of 53 out of 88 previouslyreported by Howell265 INDUCEI) OVARIAN TUMOURS IN IF MICE
et al. (1954). In the present experiments the mice were killed at pre-determined
intervals and it is to be expected that the incidence would have been higher had
the animals been allowed full survival. Ovarian tumours induced by BP have
not been reported previously. No unequivocal tumours were obtained with
MC or DB, although pre-tumourous changes followed treatment with MC.
Sequence ofovarian changes
The first ovarian effect ofDMB, BP or MC is damage to the ovum and this is
followed by degeneration of all the existing follicles and failure of new folhcles
to develop. These effects are rather more rapid with DMB than with the other
two chemicals. Abnormalities ofluteinisation are followed by the appearance of
iiodules (Fig. 9 and 10). These are derived from theca-lutein cells and arethought
to be thestartingpoint ofthe tumours ofthegranulosa cell series. These nodules
may be bilateral, although the tumours are always unilateral, and it is therefore
suggested that some regress. The final stage in the development of the nodules
into tumours was seen after DMB and BP treatment but was not reached after
MC treatment in these experiments. From histological examination it is not
possible to be certain when the growth of the nodules becomes autonomous. If
nodules fail to develop, or regress, the ovaries undergo regressive changes charac-
terisedchieflybyproliferation ofthe cells ofthegerminalepithelium, which stream
inwards to replace the lutein tissue.
By contrast, the changes observed after DB treatment resemble those seen in
ageing normal virgins. Total loss of follicles did not occur, abnormal types of
luteinisation and nodules were absent and there were no tumours. Thespecificity
of action on the ovary of these chemicals, all of which are carcinogenic to other
organs (e.g. the skin), is thus apparent.
The histogenesis of the tumours induced by DMB and BP is similar to that
seen in irradiated ovaries (Brambell and Parkes, 1927 ; Giest, Gaines and
Pollack, 1939) and in intrasplenic ovarian grafts (Biskind and Biskind, 1949).
The sequence of events after chemicals may include a transitional luteomatous
stage but this phase seems to be less persistent than that observed by Lipschutz
(1960) and Lipschutz, Rojas, Cerisola and Iglesias (1960) in intrasplenic or
fragmented ovaries. From the present experiments it appears that granulosa
cell tumours can arise from areas of abnormal luteinisation, without an inter-
vening luteomatous phase, but this is not certain.
Relation between the occurrence ofovarian and breast tunwurs
Following DMB, ovarian and breast tumours frequently occurred in the same
mouse but there was no such association when the carcinogen was BP, MC or
DB. Marchant (1959) made the interesting observation that ovarian tumours
did notdevelop in normal mouse ovariesgrafted into DMB-treated mice, although
breast tumours did occur, and that the ovaries oftreated mice diddevelop ovarian
tumours when grafted into normal mice.
Hormonal effects of the ovarian tunwurs
Of the 12 mice bearing DMB-induced tumours, there were 5 in which cystic hyperplasia of the uterus was observed (Table IV), and it was also present in the
one mouse with alarge BP-induced tumour. However, it is an inconstant feature266 JER K. MODY
and can only be regarded as a crude index of secretory activity, depending on
the ratio of oestrogen to progesterone rather than upon actual quantities. When
the BP-induced tumour was grafted into male mice evidence of a feminising effect
was seen in lobular development in the breast, suppression of spermatogenesis
and lack of secretion in the seminal vesicles.
SUMMARY
Limited skin applications of four carcinogens (DMB, BP, MC and DB) were
made to inbred virgin IF mice, which were subsequently killed at ages ranging
from 16 to 70 weeks in order that the sequence of ovarian changes might be
studied.
Ovarian tumours of the granulosa-cell series were induced by means of DMB
and BP, but not with MC or DB. The induction period was shorter with DMB.
Pre-tumorous changes were induced with MC, but DB exerted no effect upon the
ovary.
The tumours were unilateral and of the granulosa cell series, the granulosa
cell type being predominant. They resembled those occurring spontaneously
in some strains of mice, those induced by X-irradiation or in intrasplenic ovarian
grafts in castrates and the granulosa cell tumours of the human ovary.
The sequence of histological changes in the ovary after treatment with DMB,
BP or MC is death of the ova and degeneration of all the follicles, failure of new
follicles to develop, merging of the corpora lutea, proliferation and luteinisation
of theca cells and formation of multifocal nodules from these luteinised theca
cells in one or both ovaries. The tumours arise unilaterally in one or more
nodules, the remainder of which undergo regression. The secondary proliferation
and luteinisation of the theca cells following merging of the corpora lutea, with
subsequent nodule formation, is regarded as the essential precursor of tumour
formation. The ovary contralateral to the tumour-bearing ovary, or both ovaries
where no tumour is present, undergoes reduction in size. This is characterised by
a streaming into the substance ofthe ovary ofdark staining cells derived from the
germinal epithelium and the accumulation of lipochrome pigment in phagocytes.
Following treatment with DB the normal age changes which take place in
virgins occur (Mody, 1960). Large cystic follicles, persistent corpora lutea,
fibrous scars and hyaline degeneration of blood vessel walls are more frequent
than in the normal and some ovaries become greatly reduced in size.
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